Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis

References

1. 1.↵
   2. Kutzelnigg A,
   3. Lucchinetti CF,
   4. Stadelmann C, et al

   . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705–12 doi:10.1093/brain/awh641 pmid:16230320

   Abstract/FREE Full Text
2. 2.↵
   2. Peruzzo D,
   3. Castellaro M,
   4. Calabrese M, et al

   . Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study. J Cereb Blood Flow Metab 2013;33:457–63 doi:10.1038/jcbfm.2012.192 pmid:23250108

   Abstract/FREE Full Text
3. 3.↵
   2. Calabrese M,
   3. Agosta F,
   4. Rinaldi F, et al

   . Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144–50 pmid:19752305

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Calabrese M,
   3. Poretto V,
   4. Favaretto A, et al

   . Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 2012;135:2952–61 doi:10.1093/brain/aws246 pmid:23065788

   Abstract/FREE Full Text
5. 5.↵
   2. Yao B,
   3. Hametner S,
   4. van Gelderen P, et al

   . 7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PLoS One 2014;9:e108863 doi:10.1371/journal.pone.0108863 pmid:25303286

   CrossRefPubMed
6. 6.↵
   2. Aviv RI,
   3. Francis PL,
   4. Tenenbein R, et al

   . Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique. AJNR Am J Neuroradiol 2012;33:1779–85 doi:10.3174/ajnr.A3060 pmid:22538071

   Abstract/FREE Full Text
7. 7.↵
   2. Adhya S,
   3. Johnson G,
   4. Herbert J, et al

   . Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006;33:1029–35 doi:10.1016/j.neuroimage.2006.08.008 pmid:16996280

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Law M,
   3. Saindane AM,
   4. Ge Y, et al

   . Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231:645–52 doi:10.1148/radiol.2313030996 pmid:15163806

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Debernard L,
   3. Melzer TR,
   4. Van Stockum S, et al

   . Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2014;85:544–51 doi:10.1136/jnnp-2013-305612 pmid:24039024

   Abstract/FREE Full Text
10. 10.↵
    2. Francis PL,
    3. Jakubovic R,
    4. O'Connor P, et al

    . Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis. AJNR Am J Neuroradiol 2013;34:62–67 doi:10.3174/ajnr.A3148 pmid:22700746

    Abstract/FREE Full Text
11. 11.↵
    2. Carroll TJ,
    3. Horowitz S,
    4. Shin W, et al

    . Quantification of cerebral perfusion using the “bookend technique”: an evaluation in CNS tumors. Magn Reson Imaging 2008;26:1352–59 doi:10.1016/j.mri.2008.04.010 pmid:18538523

    CrossRefPubMed
12. 12.↵
    2. Shin W,
    3. Horowitz S,
    4. Ragin A, et al

    . Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation of reproducibility and age- and gender-dependence with fully automatic image postprocessing algorithm. Magn Reson Med 2007;58:1232–41 doi:10.1002/mrm.21420 pmid:17969025

    CrossRefPubMed
13. 13.↵
    2. Ashburner J,
    3. Friston KJ

    . Unified segmentation. Neuroimage 2005;26:839–51 doi:10.1016/j.neuroimage.2005.02.018 pmid:15955494

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Shah MK,
    3. Shin W,
    4. Parikh VS, et al

    . Quantitative cerebral MR perfusion imaging: preliminary results in stroke. J Magn Reson Imaging 2010;32:796–802 doi:10.1002/jmri.22302 pmid:20882609

    CrossRefPubMed
15. 15.↵
    2. Srour JM,
    3. Shin W,
    4. Shah S, et al

    . SCALE-PWI: a pulse sequence for absolute quantitative cerebral perfusion imaging. J Cereb Blood Flow Metab 2011;31:1272–82 doi:10.1038/jcbfm.2010.215 pmid:21157469

    Abstract/FREE Full Text
16. 16.↵
    2. Rempp KA,
    3. Brix G,
    4. Wenz F, et al

    . Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41 doi:10.1148/radiology.193.3.7972800 pmid:7972800

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Sakaie KE,
    3. Shin W,
    4. Curtin KR, et al

    . Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging 2005;21:512–19 doi:10.1002/jmri.20305 pmid:15834910

    CrossRefPubMed
18. 18.↵
    2. Dineen RA,
    3. Vilisaar J,
    4. Hlinka J, et al

    . Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009;132:239–49 pmid:18953055

    Abstract/FREE Full Text
19. 19.↵
    2. Roosendaal SD,
    3. Geurts JJ,
    4. Vrenken H, et al

    . Regional DTI differences in multiple sclerosis patients. Neuroimage 2009;44:1397–403 doi:10.1016/j.neuroimage.2008.10.026 pmid:19027076

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Rocca MA,
    3. Amato MP,
    4. De Stefano N, et al

    ; MAGNIMS Study Group. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 2015;14:302–17 doi:10.1016/S1474-4422(14)70250-9 pmid:25662900

    CrossRefPubMed
21. 21.↵
    2. Sánchez MP,
    3. Nieto A,
    4. Barroso J, et al

    . Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis. Eur J Neurol 2008;15:1091–99 doi:10.1111/j.1468-1331.2008.02259.x pmid:18727673

    CrossRefPubMedWeb of Science
22. 22.↵
    2. van Horssen J,
    3. Brink BP,
    4. de Vries HE, et al

    . The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007;66:321–28 doi:10.1097/nen.0b013e318040b2de pmid:17413323

    Abstract/FREE Full Text
23. 23.↵
    2. Brink BP,
    3. Veerhuis R,
    4. Breij EC, et al

    . The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64:147–55 doi:10.1093/jnen/64.2.147 pmid:15751229

    CrossRefPubMed
24. 24.↵
    2. Rao SM,
    3. Leo GJ,
    4. Bernardin L, et al

    . Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685–91 doi:10.1212/WNL.41.5.685 pmid:2027484

    Abstract/FREE Full Text
25. 25.↵
    2. Rovaris M,
    3. Yousry T,
    4. Calori G, et al

    . Sensitivity and reproducibility of fast-FLAIR, FSE, and TGSE sequences for the MRI assessment of brain lesion load in multiple sclerosis: a preliminary study. J Neuroimaging 1997;7:98–102 doi:10.1111/jon19977298 pmid:9128448

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Bakshi R,
    3. Ariyaratana S,
    4. Benedict RH, et al

    . Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742–48 doi:10.1001/archneur.58.5.742 pmid:11346369

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Benedict RH,
    3. Zivadinov R

    . Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006;245:67–72 doi:10.1016/j.jns.2005.05.020 pmid:16626751

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Geurts JJ,
    3. Barkhof F

    . Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841–51 doi:10.1016/S1474-4422(08)70191-1 pmid:18703006

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Giorgio A,
    3. Stromillo ML,
    4. Rossi F, et al

    . Cortical lesions in radiologically isolated syndrome. Neurology 2011;77:1896–99 doi:10.1212/WNL.0b013e318238ee9b pmid:22076541

    Abstract/FREE Full Text
30. 30.↵
    2. Klaver R,
    3. De Vries HE,
    4. Schenk GJ, et al

    . Grey matter damage in multiple sclerosis: a pathology perspective. Prion 2013;7:66–75 doi:10.4161/pri.23499 pmid:23324595

    CrossRefPubMed
31. 31.↵
    2. Stadelmann C,
    3. Wegner C,
    4. Brück W

    . Inflammation, demyelination, and degeneration: recent insights from ms pathology. Biochim Biophys Acta 2011;1812:275–82 doi:10.1016/j.bbadis.2010.07.007 pmid:20637864

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Magliozzi R,
    3. Howell O,
    4. Vora A, et al

    . Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089–104 pmid:17438020

    Abstract/FREE Full Text
33. 33.↵
    2. Craner MJ,
    3. Newcombe J,
    4. Black JA, et al

    . Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and NA+/CA2+ exchanger. Proc Natl Acad Sci U S A 2004;101:8168–73 doi:10.1073/pnas.0402765101 pmid:15148385

    Abstract/FREE Full Text
34. 34.↵
    2. Stys PK

    . Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies? Ann Neurol 2004;55:601–03 doi:10.1002/ana.20082 pmid:15122698

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Waxman SG

    . The neuron as a dynamic electrogenic machine: modulation of sodium-channel expression as a basis for functional plasticity in neurons. Philos Trans R Soc Lond B Biol Sci 2000;355:199–213 doi:10.1098/rstb.2000.0559 pmid:10724456

    Abstract/FREE Full Text
36. 36.↵
    2. Geurts JJ,
    3. Wolswijk G,
    4. Bö L, et al

    . Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 2003;126:1755–66 doi:10.1093/brain/awg179 pmid:12805104

    Abstract/FREE Full Text
37. 37.↵
    2. Parry AM,
    3. Scott RB,
    4. Palace J, et al

    . Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 2003;126:2750–60 doi:10.1093/brain/awg284 pmid:12958082

    Abstract/FREE Full Text
38. 38.↵
    2. Hojjat S,
    3. Cantrell C,
    4. Carroll T, et al

    . Bookend perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients. Mult Scler 2016 Feb 4. [Epub ahead of print] pmid:26846987

    Abstract/FREE Full Text
39. 39.↵
    2. Haìjek M,
    3. Benoit-Cattin H

    ; European Cooperation in the Field of Scientific and Technical Research (organizace), et al. Texture Analysis for Magnetic Resonance Imaging. Prague: Med4publishing; 2006
40. 40.↵
    2. Harrison LC,
    3. Raunio M,
    4. Holli KK, et al

    . MRI texture analysis in multiple sclerosis: toward a clinical analysis protocol. Acad Radiol 2010;17:696–707 doi:10.1016/j.acra.2010.01.005 pmid:20457414

    CrossRefPubMed